Page 3 - ஆயுட்காலம் வாழ்க்கை அறிவியல் தொடர்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CRCbioscreen announces publication of clinical validation data of a multitarget fecal immunochemical test for colorectal cancer screening

CRCbioscreen announces publication of clinical validation data of a multitarget fecal immunochemical test for colorectal cancer screening
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Noord hollandPrnewswire crcbioscreenGerrit meijerNetherlands cancer instituteLifespring life sciences communicationColorectal cancerMeike de witNetherlands cancerSpring life sciences communicationநூற்த் ஹாலண்ட்கெரிட் மேஜெற்நெதர்லாந்து புற்றுநோய் நிறுவனம்ஆயுட்காலம் வாழ்க்கை அறிவியல் தொடர்புபெருங்குடல் புற்றுநோய்நெதர்லாந்து புற்றுநோய்வசந்த வாழ்க்கை அறிவியல் தொடர்பு

Novigenix Wins the 2021 Felix Burda Award in Medicine & Science

Novigenix Wins the 2021 Felix Burda Award in Medicine & Science
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Noord hollandBrian hashemiKostenloser wertpapierhandelValentin matillonChristoph beglingerBerndt birknerDepartment of gastroenterologyFelix burda foundationUniversity hospital baselLifespring life sciences communicationEarly detectionBurda awardFelix burda awardFelix burda award juryExecutive chairmanChief business

Pharming signs agreement with NewBridge Pharmaceuticals for the commercialization of RUCONEST in the Middle East and North Africa

(1) LEIDEN, Netherlands, July 20, 2021 /PRNewswire/ Pharming Group N.V. ( Pharming or the Company ) (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces it has entered into an exclusive licence agreement with NewBridge Pharmaceuticals ( NewBridge ) for the distribution of RUCONEST (conestat alfa) in the Middle East and North Africa ( MENA ). NewBridge, headquartered in Dubai, United Arab Emirates, is a regional specialty company, with a comprehensive pharmaceutical platform of services and expertise, established to bridge the access gap and partner with global pharma and biotech companies to in-license and commercialize US Food and Drug Administration (FDA) or European Medicines Agency (EMA) approved innovative therapeutics that address unmet medical needs into MENA.

United arab emiratesUnited statesUnited kingdomCity ofNoord hollandSusanne embletonFoster mitchell alex shawDrug administrationNewbridge pharmaceuticalsExchange commissionPrnewswire pharming groupnvEuropean unionEuropean medicines agencyPharming groupLifespring life sciences communicationCompany euronext amsterdam

Intravacc s inactivated polio vaccine, out licensed to Sinovac, receives market authorization in China

Intravacc s inactivated polio vaccine, out licensed to Sinovac, receives market authorization in China
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Noord hollandMirjam hartmanIntravacc veroCoronavac sinovacSinovac covidPrnewswire intravaccSinovac eupolioSinovac biotechChinese national medical products administrationMelinda gates foundationLifespring life sciences communicationInactivated polio vaccinesJan groenRespiratory syncytial virusUtrecht science park bilthovenSpring life sciences communication

Pharming signs agreement with NewBridge Pharmaceuticals for the commercialization of RUCONEST® in the Middle East and North Africa

Pharming signs agreement with NewBridge Pharmaceuticals for the commercialization of RUCONEST® in the Middle East and North Africa USA - English Share this article Share this article LEIDEN, Netherlands, July 20, 2021 /PRNewswire/ Pharming Group N.V. ( Pharming or the Company ) (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces it has entered into an exclusive licence agreement with NewBridge Pharmaceuticals ( NewBridge ) for the distribution of RUCONEST® (conestat alfa) in the Middle East and North Africa ( MENA ). NewBridge, headquartered in Dubai, United Arab Emirates, is a regional specialty company, with a comprehensive pharmaceutical platform of services and expertise, established to bridge the access gap and partner with global pharma and biotech companies to in-license and commercialize US Food and Drug Administration (FDA) or European Medicines Agency (EMA) approved innovative therapeutics that address unmet medical needs into MENA.

United arab emiratesUnited statesUnited kingdomCity ofNoord hollandSusanne embletonFoster mitchell alex shawDrug administrationNewbridge pharmaceuticalsExchange commissionPrnewswire pharming groupnvEuropean unionEuropean medicines agencyPharming groupLifespring life sciences communicationCompany euronext amsterdam